We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

67 hedge funds and large institutions have $177M invested in Minerva Neurosciences in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 19

4% more capital invested

Capital invested by funds: $170M → $177M (+$6.5M)

0.03% more ownership

Funds ownership: 9.08% → 9.11% (+0.03%)

0% more funds holding

Funds holding: 67 → 67 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

Holders
67
Holders Change
–
Holders Change %
0%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
23
Reduced
19
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.19M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.28M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$552K
4
HCMT
Highland Capital Management (Texas)
Texas
+$519K
5
AG
Artal Group
Luxembourg
+$292K

Top Sellers

Rank Fund Capital Flow
1
AC
Ascend Capital
California
-$4.96M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$669K
3
JP Morgan Chase
JP Morgan Chase
New York
-$348K
4
BlackRock
BlackRock
New York
-$339K
5
Deutsche Bank
Deutsche Bank
Germany
-$165K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$370K +$50.5K +1,050 +17%
Swiss National Bank
27
Swiss National Bank
Switzerland
$359K +$36K +750 +12%
AA
28
ALPS Advisors
Colorado
$324K +$54.2K +1,127 +21%
Renaissance Technologies
29
Renaissance Technologies
New York
$323K -$93.1K -1,938 -23%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$311K – – –
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$308K +$160K +3,324 +117%
Charles Schwab
32
Charles Schwab
California
$296K – – –
AllianceBernstein
33
AllianceBernstein
Tennessee
$275K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$256K -$31.3K -651 -11%
Deutsche Bank
35
Deutsche Bank
Germany
$255K -$165K -3,437 -40%
TI
36
Trexquant Investment
Connecticut
$207K +$31.3K +651 +19%
Squarepoint
37
Squarepoint
New York
$195K +$35K +728 +23%
UBS AM
38
UBS AM
Illinois
$165K +$36.6K +762 +30%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$160K – – –
Goldman Sachs
40
Goldman Sachs
New York
$158K -$93.4K -1,944 -38%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$145K -$1.01K -21 -0.7%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$144K -$1.1K -23 -0.8%
ProShare Advisors
43
ProShare Advisors
Maryland
$133K -$21K -438 -14%
AWCI
44
Alpine Woods Capital Investors
New York
$125K – – –
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$112K – – –
AIG
46
American International Group
New York
$106K -$5.43K -113 -5%
OAM
47
Oxford Asset Management
United Kingdom
$98K +$93.9K +1,955 New
CS
48
Credit Suisse
Switzerland
$89K +$6.58K +137 +8%
RJFSA
49
Raymond James Financial Services Advisors
Florida
$88K +$84.1K +1,750 New
Wells Fargo
50
Wells Fargo
California
$82K +$288 +6 +0.4%
1
2
3

NERV Hedge Fund Activity: Q1 2018 in Review

67 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2018, worth a combined $177M — up 3.8% from $170M a quarter earlier.

Fund positioning in NERV was balanced in Q1 2018: 8 funds opened new positions, 8 closed out, 23 added to existing stakes and 19 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.19M. The largest seller was Ascend Capital, exiting entirely with an estimated $4.96M sold.

  • 67 institutional investors held Minerva Neurosciences (NERV) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $177M of Minerva Neurosciences stock for Q1 2018, up 3.8% quarter-over-quarter.
  • 8 funds opened new Minerva Neurosciences positions in Q1 2018 and 8 closed out, a net change of 0 holders.
  • The largest Minerva Neurosciences buyer in Q1 2018 was Millennium Management, an estimated $4.19M added.
  • The largest Minerva Neurosciences seller in Q1 2018 was Ascend Capital, an estimated $4.96M sold.

Based on aggregated 13F filings for Q1 2018.